-
Pfizer accused of ‘bullying’ Latin American countries during vaccine negotiations
pharmaceutical-technology
February 24, 2021
Latin American countries have accused Pfizer of ‘high-level bullying’ during Covid-19 vaccine negotiations, according to a report by the Bureau of Investigative Journalism published in partnership with STAT.
-
India sends first COVID-19 vaccine shipment to Africa under COVAX programme
expresspharma
February 24, 2021
India sent its first shipment of locally made COVID-19 vaccines to the WHO-backed equitable vaccine distribution network COVAX on Tuesday.
-
J&J Announces Single-Shot Janssen COVID-19 Vaccine Candidate Submission to WHO
americanpharmaceuticalreview
February 23, 2021
Johnson & Johnson announced Janssen-Cilag International has submitted for Emergency Use Listing (EUL) to the World Health Organization (WHO) for the investigational single-dose Janssen COVID-19 vaccine candidate.
-
Novavax concludes subject enrolment in Covid-19 vaccine trial
pharmaceutical-technology
February 23, 2021
Biotechnology company Novavax has concluded enrolment in its pivotal Phase III PREVENT-19 study of Covid-19 vaccine candidate, NVX-CoV2373, in the US and Mexico.
-
EU contributes extra €500m to COVAX facility for Covid-19 vaccine supply
pharmaceutical-technology
February 23, 2021
The European Union (EU) doubles its contribution to date by providing an additional €500m for the COVAX Facility, a global initiative for securing fair and equitable access to safe and effective Covid-19 vaccines in low and middle-income countries.
-
Russia grants approval to third Covid-19 vaccine for domestic use
pharmaceutical-technology
February 23, 2021
Russia has granted approval to its third Covid-19 vaccine for domestic use, with large-scale clinical trials yet to begin.
-
WHO agrees on compensation plan in case of serious side effects of COVAX vaccine
expresspharma
February 23, 2021
By providing a no-fault lump-sum compensation in full and final settlement of any claims, the COVAX programme aims to significantly reduce the need for recourse to the law courts, a potentially lengthy and costly process, informed WHO.
-
GSK, Sanofi begin new COVID-19 vaccine study after setback
expresspharma
February 23, 2021
The companies aim to reach final testing in the second quarter, and if the results are conclusive, hope to see the vaccine approved by the fourth quarter.
-
New social media campaign launched to support COVID-19 vaccine roll-out in the UK
pharmatimes
February 22, 2021
A new social media campaign, launched by the UK government and the NHS, will allow people to show their support for the COVID-19 vaccine roll-out from today.
-
Evonik Announces Partnership with BioNTech for COVID-19 Vaccine
americanpharmaceuticalreview
February 22, 2021
Evonik is investing in the short-term expansion of its specialty lipids production which are essential for mRNA-based COVID-19 vaccines.